Literature DB >> 10993895

Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy.

M Matsuo1, S Trapp, Y Tanizawa, N Kioka, T Amachi, Y Oka, F M Ashcroft, K Ueda.   

Abstract

The ATP-sensitive potassium (K(ATP)(+)) channel is crucial for the regulation of insulin secretion from the pancreatic beta-cell, and mutations in either the sulfonylurea receptor type 1 (SUR1) or Kir6. 2 subunit of this channel can cause persistent hyperinsulinemic hypoglycemia of infancy (PHHI). We analyzed the functional consequences of the PHHI missense mutation R1420C, which lies in the second nucleotide-binding fold (NBF2) of SUR1. Mild tryptic digestion of SUR1 after photoaffinity labeling allowed analysis of the nucleotide-binding properties of NBF1 and NBF2. Labeling of NBF1 with 8-azido-[alpha-(32)P]ATP was inhibited by MgATP and MgADP with similar K(i) for wild-type SUR1 and SUR1-R1420C. However, the MgATP and MgADP affinities of NBF2 of SUR1-R1420C were about 5-fold lower than those of wild-type SUR1. MgATP and MgADP stabilized 8-azido-ATP binding at NBF1 of wild-type SUR1 by interacting with NBF2, but this cooperative nucleotide binding was not observed for SUR1-R1420C. Studies on macroscopic currents recorded in inside-out membrane patches revealed that the SUR1-R1420C mutation exhibits reduced expression but does not affect inhibition by ATP or tolbutamide or activation by diazoxide. However, co-expression with Kir6.2-R50G, which renders the channel less sensitive to ATP inhibition, revealed that the SUR1-R1420C mutation increases the EC(50) for MgADP activation from 74 to 197 microm. We suggest that the lower expression of the mutant channel and the reduced affinity of NBF2 for MgADP may lead to a smaller K(ATP)(+) current in R1420C-PHHI beta-cells and thereby to the enhanced insulin secretion. We also propose a new model for nucleotide activation of K(ATP)(+) channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993895     DOI: 10.1074/jbc.M006503200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels.

Authors:  Yu-Wen Lin; Courtney MacMullen; Arupa Ganguly; Charles A Stanley; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2005-12-06       Impact factor: 5.157

3.  Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.

Authors:  E A Cartier; L R Conti; C A Vandenberg; S L Shyng
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 4.  Advances in the diagnosis and management of hyperinsulinemic hypoglycemia.

Authors:  Ritika R Kapoor; Chela James; Khalid Hussain
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

5.  Kir6.2 mutations causing neonatal diabetes prevent endocytosis of ATP-sensitive potassium channels.

Authors:  Jamel Mankouri; Tarvinder K Taneja; Andrew J Smith; Sreenivasan Ponnambalam; Asipu Sivaprasadarao
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

Review 6.  Potassium channel regulation.

Authors:  Jeff D Campbell; Mark S P Sansom; Frances M Ashcroft
Journal:  EMBO Rep       Date:  2003-11       Impact factor: 8.807

7.  Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.

Authors:  Ritika R Kapoor; Sarah E Flanagan; Ved Bhushan Arya; Julian P Shield; Sian Ellard; Khalid Hussain
Journal:  Eur J Endocrinol       Date:  2013-03-15       Impact factor: 6.664

8.  The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.

Authors:  Veronica Lang; Peter E Light
Journal:  Pharmgenomics Pers Med       Date:  2010-11-24

9.  Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation.

Authors:  Akiko Saito-Hakoda; Tohru Yorifuji; Junko Kanno; Shigeo Kure; Ikuma Fujiwara
Journal:  Clin Pediatr Endocrinol       Date:  2012-07-25

10.  ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes.

Authors:  Leslie J Baier; Yunhua Li Muller; Maria Sara Remedi; Michael Traurig; Paolo Piaggi; Gregory Wiessner; Ke Huang; Alyssa Stacy; Sayuko Kobes; Jonathan Krakoff; Peter H Bennett; Robert G Nelson; William C Knowler; Robert L Hanson; Colin G Nichols; Clifton Bogardus
Journal:  Diabetes       Date:  2015-08-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.